Mapping the paratope of anti-CD4 recombinant fab 13B8.2 by combining parallel peptide synthesis and site-directed mutagenesis

被引:20
作者
Bès, C
Briant-Longuet, L
Cerutti, M
Heitz, F
Troadec, S
Pugnière, M
Roquet, F
Molina, F
Casset, F
Bresson, D
Péraldi-Roux, S
Devauchelle, G
Devaux, C
Granier, C
Chardès, T
机构
[1] CNRS, UMR 5094, Inst Biotechnol & Pharmacol, Fac Pharm, Montpellier 5, France
[2] CNRS, UMR 5121, Lab Infect Retrovirales & Signalisat Cellulaire, Inst Biol, F-34060 Montpellier 2, France
[3] INRA, CNRS, UMR 5087, Lab Pathol Comparee, F-30380 St Christol Les Ales, France
[4] CNRS, UPR 1086, Ctr Rech Biochim Macromol, F-34293 Montpellier 5, France
[5] Syntem, F-30035 Nimes 1, France
关键词
D O I
10.1074/jbc.M210694200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
We analyzed antigen-binding residues from the variable domains of anti-CD4 antibody 13B8.2 using the Spot method of parallel peptide synthesis. Sixteen amino acids, defined as Spot critical residues (SCR), were identified on the basis of a 50% decrease in CD4 binding to alanine analogs of reactive peptides. Recombinant Fab 13B8.2 mutants were constructed with alanine residues in place of each of the 16 SCR, expressed in the baculovirus cell system, and purified. CD measurements indicated that the mutated proteins were conformationally intact, with a beta-sheet secondary structure similar to that of wild-type Fab. Compared with the CD4-binding capacity of wildtype Fab 13B8.2, 11 light (Y32-L, W35-L, Y36-L, H91-L, and Y92-L) and heavy chain (H35-H, R38-H, W52-H, R53-H, F100K-H, and W103-H) Fab single mutants showed a decrease in CD4 recognition as demonstrated by enzymelinked immunosorbent assay, BIAcore, and flow cytometry analyses. The five remaining Fab mutants showed antigen-binding properties similar to those of wild-type Fab. Recombinant Fab mutants that showed decreased CD4 binding also lost their capacity to inhibit human immunodeficiency virus promoter activation and the antigen-presenting ability that wild-type Fab displays. Molecular modeling of the 13B8.2 antibody paratope indicated that most of these critical residues are appropriately positioned inside the putative CD4-binding pocket, whereas the five SCR that were not confirmed by mutagenesis show an unfavorable positioning. Taken together, these results indicate that most of the residues defined by the Spot method as critical matched with important residues defined by mutagenesis in the whole protein context. The identification of critical residues for CD4 binding in the paratope of anti-CD4 recombinant Fab 13B8.2 provides the opportunity for the generation of improved anti-CD4 molecules with more efficient pharmacological properties.
引用
收藏
页码:14265 / 14273
页数:9
相关论文
共 46 条
[31]  
Pearlman R S, 1991, NIDA Res Monogr, V112, P62
[32]   Design of cassette baculovirus vectors for the production of therapeutic antibodies in insect cells [J].
Poul, MA ;
Cerutti, M ;
Chaabihi, H ;
Devauchelle, G ;
Kaczorek, M ;
Lefranc, MP .
IMMUNOTECHNOLOGY, 1995, 1 (3-4) :189-196
[33]   SEVERAL CD4 DOMAINS CAN PLAY A ROLE IN HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION OF CELLS [J].
POULIN, L ;
EVANS, LA ;
TANG, SB ;
BARBOZA, A ;
LEGG, H ;
LITTMAN, DR ;
LEVY, JA .
JOURNAL OF VIROLOGY, 1991, 65 (09) :4893-4901
[34]   A natural antibody missing a cysteine in V-H: Consequences for thermodynamic stability and folding [J].
Proba, K ;
Honegger, A ;
Pluckthun, A .
JOURNAL OF MOLECULAR BIOLOGY, 1997, 265 (02) :161-172
[35]  
Pulito VL, 1996, J IMMUNOL, V156, P2840
[36]  
REES AR, 1992, ABM COMPUTER PROGRAM
[37]   A humanized form of a CD4-specific monoclonal antibody exhibits decreased antigenicity and prolonged plasma half-life in rhesus monkeys while retaining its unique biological and antiviral properties [J].
Reimann, KA ;
Lin, WY ;
Bixler, S ;
Browning, B ;
Ehrenfels, BN ;
Lucci, J ;
Miatkowski, K ;
Olson, D ;
Parish, TH ;
Rosa, MD ;
Oleson, FB ;
Hsu, YM ;
Padlan, EA ;
Letvin, NL ;
Burkly, LC .
AIDS RESEARCH AND HUMAN RETROVIRUSES, 1997, 13 (11) :933-943
[38]   A synthetic mimic of a discontinuous binding site on interleukin-10 [J].
Reineke, U ;
Sabat, R ;
Misselwitz, R ;
Welfle, H ;
Volk, HD ;
Schneider-Mergener, J .
NATURE BIOTECHNOLOGY, 1999, 17 (03) :271-275
[39]   Identification of distinct antibody epitopes and mimotopes from a peptide array of 5520 randomly generated sequences [J].
Reineke, U ;
Ivascu, C ;
Schlief, M ;
Landgraf, C ;
Gericke, S ;
Zahn, G ;
Herzel, H ;
Volkmer-Engergt, R ;
Schneider-Mergener, J .
JOURNAL OF IMMUNOLOGICAL METHODS, 2002, 267 (01) :37-51
[40]   Substrate specificity of the DnaK chaperone determined by screening cellulose-bound peptide libraries [J].
Rudiger, S ;
Germeroth, L ;
SchneiderMergener, J ;
Bukau, B .
EMBO JOURNAL, 1997, 16 (07) :1501-1507